Scientists track TB drugs in body to find best dose for cure
NCT ID NCT02563327
Summary
This study aimed to understand how the body processes high doses of two tuberculosis drugs, rifapentine and moxifloxacin. Researchers measured drug levels in the blood of 53 TB patients to see how these levels relate to how well the treatment works and its safety. The goal was to find the most effective drug doses to better control TB.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUBERCULOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Joint Clinical Research Centre/ Makerere Univ Med Sch
Kampala, Uganda
-
National TB Program
Hanoi, Vietnam
-
University of Texas Health Science Center at
San Antonio, Texas, United States
Conditions
Explore the condition pages connected to this study.